Correlación TC-Histología de la Enfermedades Intersticiales Pulmonares Asociadas a Tabaquismo.
Palabras clave:
Enfermedades Intersticiales Pulmonares, poster, seram, TabaquismoResumen
Objetivos Docentes
1. Revisar el grupo de enfermedades que constituyen las Enfermedades Intersticiales Pulmonares Asociadas a Tabaquismo.
2. Presentar la correlación entre TC e histología de las Enfermedades Intersticiales Pulmonares Asociadas a Tabaquismo más habituales.
Revisión del tema
INTRODUCCIÓN
El humo del tabaco es una toxina que contiene más de 4.000 compuestos y es el factor etiológico más importante para desarrollar cáncer de pulmón y enfermedad pulmonar obstructiva crónica (EPOC).
Recientemente se ha relacionado el humo del tabaco con el desarrollo de determinadas enfermedades intersticiales (Figura 1). Las más conocidas o “tríada tradicional” de las enfermedades intersticiales asociadas al tabaco son (1) la bronquiolitis respiratoria asociada a enfermedad intersticial pulmonar (BR-EIP), (2) la neumonía intersticial descamativa (NID) y (3) la histiocitosis de células de Langerhans pulmonar (HCLP). Un segundo grupo de enfermedades fibrosantes asociadas al tabaquismo son (1) la neumonía intersticial usual (NIU), (2) la combinación de fibrosis pulmonar y enfisema (CFPE) y (3) la neumonía intersticial no específica (NINE). Un tercer grupo lo forman procesos agudos como (1) la neumonía eosinófila aguda y (2) los síndromes hemorrágicos pulmonares.
Descargas
Citas
Attili AK, Kazerooni EA, Gross BH, Flaherty KR, Myers JL, Martinez FJ. Smoking-related Interstitial Lung Disease: Radiologic-Clinical-Pathologic Correlation. RadioGraphics 2008
Sep;28(5):1383–96.
Caminati A, Cavazza A, Sverzellati N, Harari S. An integrated approach in the diagnosis of smoking-related interstitial lung diseases. European Respiratory Review 2012 Aug
;21(125):207–17.
Castoldi MC, Verrioli A, De Juli E, Vanzulli A. Pulmonary Langerhans cell histiocytosis: the many faces of presentation at initial CT scan. Insights Imaging 2014 Aug;5(4):483–92.
Cottin V, Cordier J-F. Combined pulmonary fibrosis and emphysema in connective tissue disease. Current Opinion in Pulmonary Medicine 2012 Sep;18(5):418–27.
Cottin V, Le Pavec J, Prevot G, Mal H, Humbert M, Simonneau G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. European Respiratory Journal 2009 Dec 31;35(1):105–11.
Cottin V. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. European Respiratory Journal 2005 Oct 1;26(4):586–93.
Dias OM, Baldi BG, Costa AN, Carvalho CRR. Combined pulmonary fibrosis and emphysema: an increasingly recognized condition. Jornal Brasileiro de Pneumologia. Sociedade Brasileira de Pneumologia e Tisiologia 2014;40(3):304–12.
Flaherty KR, Fell C, Aubry M-C, Brown K, Colby T, Costabel U, et al. Smoking-related idiopathic interstitial pneumonia. Eur Respir J 2014 Sep;44(3):594–602.
Girard N, Marchand-Adam S, Naccache J-M, Borie R, Urban T, Jouneau S, et al. Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patients. J Thorac
Oncol 2014 Aug;9(8):1162–70.
Heyneman LE, Ward S, Lynch DA, Remy-Jardin M, Johkoh T, Müller NL. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? American Journal of Roentgenology 1999 Dec;173(6):1617–22.
Jankowich MD, Rounds SIS. Combined Pulmonary Fibrosis and Emphysema Syndrome. Chest 2012 Jan;141(1):222–31.
Lin H, Jiang S. Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone. J Thorac Dis 2015 Apr;7(4):767–79.
Madan R, Matalon S, Vivero M. Spectrum of Smoking-related Lung Diseases: Imaging Review and Update. J Thorac Imaging 2016 Mar;31(2):78–91.
Margaritopoulos GA, Harari S, Caminati A, Antoniou KM. Smoking-related idiopathic interstitial pneumonia: A review. Respirology 2016 Jan;21(1):57–64.
Nair A, Hansell DM. High-resolution computed tomography features of smoking-related interstitial lung disease. Semin Ultrasound CT MR 2014 Feb;35(1):59–71.
Portillo K, Morera J. Combined Pulmonary Fibrosis and Emphysema Syndrome: A New Phenotype within the Spectrum of Smoking-Related Interstitial Lung Disease. Pulmonary
Medicine 2012;2012(6):1–8.
Remy-Jardin M, Remy J, Gosselin B, Becette V, Edme JL. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993 Mar;186(3):643–51.
Sakai F, Tominaga J, Kaga A, Usui Y, Kanazawa M, Ogura T, et al. Imaging Diagnosis of Interstitial Pneumonia with Emphysema (Combined Pulmonary Fibrosis and Emphysema).
Pulmonary Medicine 2012;2012(5):1–9.
Watanabe Y, Kawabata Y, Kanauchi T, Hoshi E, Kurashima K, Koyama S, et al. Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis. Eur J Radiol 2015 May;84(5):986–92.
Wright JL, Tazelaar HD, Churg A. Fibrosis with emphysema. Histopathology 2010 Sep 21;58(4):517–24.
Yamada T, Nakanishi Y, Homma T, Uehara K, Mizutani T, Hoshi E, et al. Airspace enlargement with fibrosis shows characteristic histology and immunohistology different from usual interstitial pneumonia, nonspecific interstitial pneumonia and centrilobular emphysema. Pathol Int 2013 May 20;63(4):206–13.
Zheng KS, Henry TS, Little BP. Computed tomography of smoking-related lung disease: review and update. Current Pulmonology Reports 2015 Oct 13;4(4):179–90.
